Chlamydia trachomatis infections - A major concern for reproductive health. Where do we stand regarding epidemiology, pathogenesis, diagnosis and therapy?

European Journal of Contraception and Reproductive Health Care

Volumn 6, Issue 2, 2001, Pages 115-126

  Mardh P A ^a   Novikova, N ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chlamydia trachomatis; Diagnosis; Genital infections; Pregnancy; Therapy

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC THERAPY; BACTERIUM DETECTION; CANCER RISK; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DIAGNOSTIC TEST; DISEASE PREDISPOSITION; EPIDEMIOLOGICAL DATA; HORMONAL THERAPY; HUMAN; INTRAUTERINE INFECTION; MALE INFERTILITY; PATHOGENESIS; PATIENT MONITORING; PELVIC INFLAMMATORY DISEASE; PREMATURITY; PRIORITY JOURNAL; REINFECTION; RELAPSE; REPRODUCTIVE HEALTH; REVIEW; SERODIAGNOSIS; SPONTANEOUS ABORTION; UTERINE CERVIX CANCER;

EID: 0034897052     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.1080/ejc.6.2.115.126     Document Type: Review

References (69)

1. Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection
2. Detection of Chlamydia trachomatis in fallopian tube tissue in women with post-infectious tubal infertility
3. The role of Chlamydia pneumoniae in arteriosclerosis
4. Detection of Chlamydia pneumoniae in aortic arteriosclerosis by immunocytochemical stain
5. Chlamydia pneumoniae in human abdominal aortic aneurysms
6. Resistant chlamydial envelope antigens in antibiotic-exposed infected cells trigger neutrophil chemotaxis
7. The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection
8. Human leucocyte antigen class II DQ locus associated Chlamydia trachomatis tubal infertility
9. Inhibitory effect on the formation of chlamydial inclusion in McCoy cells by seminal fluid and some of its components
10. Multiplex AMPLICOR PCR for detection of Chlamydia trachomatis and Neisseria gonorrhoea in women attending non-sexually transmitted disease clinics
11. Sampling and specimens handling in the diagnosis of genital Chlamydia trachomatis infections. Chlamydia trachomatis in genital and related infection
12. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine
13. Antichlamydial activity of cervical secretion
14. Antichlamydial activity of tear fluid
15. Detection of PCR, inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay
16. Evaluation of the Digene Hybrid Capture II CT-IP test for detection of Chlamydia trachomatis in endocervical specimens
17. Performance characteristics of the Becton Dickinson ProbeTec System for direct detection of Chlamydia trachomatis in male and female urine specimens in comparison with the Roche Cobas System
18. Non-invasive sampling method for detecting Chlamydia trachomatis
19. Detection of Chlamydia trachomatis in urine specimens from women by ligase chain reaction (LCR)
20. Diagnosis of genital Chlamydia trachomatis infections in asymptomatic males by testing urine by PCR
21. Vulval swabs as alternative speciment for ligase chain reaction detection of genital chlamydial infection in women
22. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: A cluster-randomized 1-year follow-up study
23. Impact of menstrual cycle on the diagnostic performance of LCR, TMA and PCE for detection of Chlamydia trachomatis in home obtained and mailed vaginal flush and urine samples
24. Designing antibiotic therapeutic trial protocols for PID and evaluation of test results - A problematic task
25. Detection of Chlamydia pneumoniae TWAR in human coronary artherectomy tissue
26. Follow up of treatment: An integral part of the control of Chlamydia trachomatis infections
27. Is a test for cure necessary following treatment for clinical infection with Chlamydia trachomatis
28. Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: High therapeutic success rates despite poor compliance
29. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment of women. A use-effectiveness study in public health settings
30. Anti-microbial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method
31. Further investigating the clinical importance of heterotypic antimicrobial resistance to Chlamydia trachomatis
32. Chlamydia trachomatis and azithromycin
33. Epidemiology
34. The impact on a comprehensive chlamydia prevention program in Wisconsin
35. Use of blocking reagent to confirm enzyme immunoassay results in samples from patients with chlamydial conjunctivitis
36. Limitations of current surveillance programmes for sexually transmitted infections and conditions affecting reproductive health care
37. Improvement of surveillance programmes for sexually transmitted infections and related conditions
38. Home sampling versus conventional contact tracing for detecting Chlamydia trachomatis infection in male partners of infected women
39. A retrospective study of efforts to diagnose infections by Chlamydia trachomatis in a Swedish county
40. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women
41. Are oral contraceptives masking symptoms of chlamydia cervicitis and pelvic inflammatory disease?
42. Decrease in incidence of women treated in hospital for acute salpingitis in Sweden
43. Ectopic pregnancy. The "epidemic" seems to be over
44. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: Ecological analysis
45. Prevention of pelvic inflammatory disease (PID) by reducing the prevalence of causative agents by screening strategies
46. Analysis of ectopic pregnancy data using marginal and conditional models
47. The frequency of salpingitis and ectopic pregnancy as epidemiologic markers of Chlamydia trachomatis
48. Chronic pelvic pain in young women. The importance of differential diagnosis
49. Chlamydia trachomatis infection in preterm birth
50. Intrauterine lung infection by Chlamydia trachomatis in a premature infant
51. How well is pelvic inflammatory disease managed in genital practice? A postal questionnaire survey
52. National guidelines to the management of Chlamydia trachomatis genital tract infection
53. A typical pelvic inflammatory disease: Subacute, chronic, or subclinical upper genital tract infection in women
54. Is Europe ready for STD screening?
55. Individual immunity and susceptibility to female genital tract infection
56. The role of heat shock proteins in reproduction
57. Chlamydia trachomatis: Impact on human reproduction
58. Proliferative response to conserved epitopes of the Chlamydia trachomatis and human 60-kilodalton heat-shock proteins by lymphocytes from women with salpingitis
59. Detection of chlamydial antigenic material in ovarian, prostatic, ectopic pregnancy and semen samples of culture-negative subjects
60. Experimental epididymitis and urethritis in grivit monkeys provoked by Chlamydia trachomatis
61. Coincubation of human spermatozoa with Chlamydia trachomatis in vitro causes increased sperm protein phosphorylation and decreased sperm mobility and viability
62. In vitro tests of the adherence of Chlamydia trachomatis to human spermatozoa
63. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma
64. Persistent Chlamydia trachomatis infections resist apoptotic stimuli
65. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction
66. Comparison of different sample DNA preparations and molecular-biological techniques for the detection of Chlamydia trachomatis in synovial fluid
67. Arthritis associated with sexually transmitted diseases
68. Chlamydia trachomatis infections of the adult
69. WHO alliance for the global elimination by binding trachoma and by potential use of azotromycin